Nutritional Growth Solutions (ASX:NGS) Research & Development: A$0.00 Mil (TTM As of Dec. 2025)


What is Nutritional Growth Solutions Research & Development?

Nutritional Growth Solutions ASX:NGS Research & Development is A$0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nutritional Growth Solutions's Research & Development for the six months ended in Dec. 2025 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Nutritional Growth Solutions  (ASX:NGS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nutritional Growth Solutions Research & Development Related Terms

Nutritional Growth Solutions Research & Development Historical Data

* Premium members only.

The historical data trend for Nutritional Growth Solutions's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutritional Growth Solutions Research & Development Chart

Nutritional Growth Solutions Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.49 0.44 0.35 0.00

Nutritional Growth Solutions Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.18 0.15 0.20 0.00 0.00

Nutritional Growth Solutions Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.00 Mil mean?
Nutritional Growth Solutions (ASX:NGS) has a Research & Development of A$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nutritional Growth Solutions and its competitors.
Is Nutritional Growth Solutions' Research & Development too high?
Nutritional Growth Solutions' current Research & Development is A$0.00 Mil.
How does Nutritional Growth Solutions' Research & Development compare to KHC and GIS?
Nutritional Growth Solutions' Research & Development of A$0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nutritional Growth Solutions and its competitors. Nutritional Growth Solutions's current Research & Development is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutritional Growth Solutions stock overvalued right now?
Based on GuruFocus' analysis, Nutritional Growth Solutions (ASX:NGS) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 120% above its estimated fair value. The current Research & Development is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nutritional Growth Solutions (ASX:NGS), the current Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nutritional Growth Solutions Business Description

Address 3 Hanechoshet Street, Yafo, Tel Aviv, ISR, 6971068
Nutritional Growth Solutions Ltd is engaged in the business of developing produces and selling clinically tested protein supplements for children. It offers protein shakes and other products to improve the height and weight of children. It generates its revenues through the sale of its products directly to customers. Its brands include Horlicks, Healthy Heights, Pro Up, and Healthy Height China. Geographically it operates in the United States and the Rest of the World and the majority of its revenue comes from the united states.